Advertisement
|
|
news roundup
SGS announced that it has successfully implemented advanced techniques for the collection and use of peripheral blood mononuclear cells for early phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.
| Advertisement
A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
 Register Now |
Clinerion and Patient iP have teamed up to improve clinical trial design, site selection, and patient enrollment by globalizing access to real world data for clinical trial applications.
| Advertisement
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
Thursday, October 4, 2018 at 11am EDT
 Register Now |
A global CRO has expanded its existing partnership with OmniComm Systems, Inc. Under this partnership, this CRO has announced a $7.8 million extension agreement for OmniComm's TrialOne and will utilize OmniComm's system to ensure regulatory compliance and bring greater operational efficiency, speed, and quality to the clinical research process within its clinics.
| Advertisement
Artificial Intelligence: A Transformative Journey for Pharmacovigilance
Thursday, September 27, 2018 at 11am EDT
 Register Now |
CRF Health announced that its TrialMax Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study.
|
|
|
| Advertisement
Challenging the Status Quo: The Diffusion of Technology in Study Startup
Tuesday, September 25, 2018 at 1pm EDT | 12pm CDT | 10am PDT
 Register Now |
| Advertisement
A Next Generation Sequencing Approach to Influenza Vaccine Development
Thursday, September 20, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
 Register Now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
| Advertisement
Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
Wednesday, September 12, 2018 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST
 Register Now |
|
|
|
Articles
Assessing the benefits of using blockchain technology as a notary service in the network sharing of clinical data.
Exploring that pivotal question for clinical investigators, sponsors, and global CROs.
|
|
Blog Posts
The relationship between European patients and drug developers has gone through many twists and turns over the years—and is still seeking equilibrium.
To help combat the nation's opioid epidemic, FDA is promoting a more tailored approach to developing and testing effective analgesics, with the aim of bringing less addictive pain treatments to market more quickly.
|
|
Oncology
Here are four trends to watch as researchers continue to make headway in the development of biomarkers for cancer immunotherapy.
|
|
|
Despite the evidence that the Hispanic population is increasing at a formidable rate, they not only face disadvantages in health care access, but are significantly underrepresented as participants in biomedical research.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
